Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Open-label, multicenter, dose-escalation Phase I/II study to evaluate safety, pharmacokinetics and activity of RO5126766, a dual Raf and MEK inhibitor, administered orally as monotherapy in patients with advanced tumors https://www.kusajili.fr:443/Trial/ImWF9-zhj06UHavCHjeT2A%24open-label-multicenter-dose-escalation-phase-iii-study-to-evaluate-safety-pharmacokinetics-and-activity-of-ro5126766-a-dual-raf
I have read and accept the terms of use of the site and the Privacy Policy
Send your message